trending Market Intelligence /marketintelligence/en/news-insights/trending/ck_sxzozgnl9obceuzbz7q2 content esgSubNav
In This List

Scythian Biosciences extends letter of intent to buy medical cannabis company

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Scythian Biosciences extends letter of intent to buy medical cannabis company

Scythian Biosciences Corp. said it extended the previously announced letter of intent to buy MMJ International Investments Inc., a company pursuing medical cannabis opportunities in South America.

The companies now have until April 30 to negotiate a definitive deal, as opposed to March 31 previously.

Scythian, a Canadian medical cannabis company, added that its COO David Schrader will step down on March 31.